 | Issue navigator |
|
|
Contents of Volume 3 Suppl A
21st European Workshop for Rheumatology Research
Meeting abstracts
Vienna, Austria. 1  4 March 2001
|
Meeting abstract
The impact of DNA chip technology on molecular medicine
KK Wilgenbus
Arthritis Res 2001, 3(Suppl A):L001 (26 January 2001)
[Full text] [PDF] [PubMed] [Related articles]
Meeting abstract
Protein microarray characterization of the autoantibody response in systemic lupus erythematosus and related diseases
W Robinson, C DiGennaro, W Hueber, D Fong, B Haab, D Hirshberg, S Muller, GJ Pruijn, WJ van Venrooij, JS Smolen, PO Brown, Lawrence Steinman, Paul J Utz
Arthritis Res 2001, 3(Suppl A):L002 (26 January 2001)
[Full text] [PDF]
Meeting abstract
The integration of functional genomics, combinatorial chemistry and nanotechnology into a miniaturized drug discovery process
M Auer
Arthritis Res 2001, 3(Suppl A):L005 (26 January 2001)
[Full text] [PDF]
Meeting abstract
DNA therapeutics: a feasible option for treatment of inflammatory diseases?
E Wagner
Arthritis Res 2001, 3(Suppl A):L006 (26 January 2001)
[Full text] [PDF]
Meeting abstract
Chromosome segregation one hundred years after Mendel's rediscovery
K Nasmyth
Arthritis Res 2001, 3(Suppl A):L007 (26 January 2001)
[Full text] [PDF]
Meeting abstract
Genetic analysis of the pentraxin genes in SLE
AI Russell, CA Roberton, S Chadha, DS Cunninghame Graham, TJ Vyse
Arthritis Res 2001, 3(Suppl A):L008 (26 January 2001)
[Full text] [PDF]
Meeting abstract
The role of DNA in the pathogenesis of SLE
DS Pisetsky
Arthritis Res 2001, 3(Suppl A):L009 (26 January 2001)
[Full text] [PDF]
Meeting abstract
Gene expression analysis of Th1 and Th2 cells: clues to homing in inflammation
F Sinigaglia
Arthritis Res 2001, 3(Suppl A):L010 (26 January 2001)
[Full text] [PDF]
Meeting abstract
From perinuclear factor to citrulline, a target structure for autoantibodies in rheumatoid arthritis
G Serre
Arthritis Res 2001, 3(Suppl A):L012 (26 January 2001)
[Full text] [PDF]
Meeting abstract
Anti-inflammatory activity of statins: potential use in the anti-phospholipid syndrome
PL Meroni
Arthritis Res 2001, 3(Suppl A):L013 (26 January 2001)
[Full text] [PDF]
Meeting abstract
The place of mitochondria in apoptosis
G Kroemer
Arthritis Res 2001, 3(Suppl A):L016 (26 January 2001)
[Full text] [PDF]
Meeting abstract
New approaches to inhibiting TNF production in rheumatoid arthritis: is pathological TNF regulated in the same way as protective TNF?
M Feldmann, B Foxwell, R Maini, F Brennan
Arthritis Res 2001, 3(Suppl A):L017 (26 January 2001)
[Full text] [PDF]
Meeting abstract
Cytokine signalling: new insights and new opportunities for therapeutic intervention?
JJ O'Shea
Arthritis Res 2001, 3(Suppl A):L018 (26 January 2001)
[Full text] [PDF]
Meeting abstract
The pathogenesis of vasculitis
CGM Kallenberg
Arthritis Res 2001, 3(Suppl A):L019 (26 January 2001)
[Full text] [PDF]
Meeting abstract
The pathogenesis of osteoarthritis: potential targets for therapy
S Abramson
Arthritis Res 2001, 3(Suppl A):L020 (26 January 2001)
[Full text] [PDF]
Meeting abstract
The role of "nurse-like cells" in bone resorbtion observed in patients with RA
T Ochi
Arthritis Res 2001, 3(Suppl A):L021 (26 January 2001)
[Full text] [PDF]
Meeting abstract
Molecular events in cartilage formation and remodeling
Dick Heinegård
Arthritis Res 2001, 3(Suppl A):L023 (26 January 2001)
[Full text] [PDF]
Meeting abstract
The molecular mechanism of osteoclastogenesis: ODF/RANKL-dependent and independent pathways
T Suda, N Takahashi, N Udagawa, C Miyaura
Arthritis Res 2001, 3(Suppl A):L024 (26 January 2001)
[Full text] [PDF]
Meeting abstract
Normal and pathological bone development controlled by the AP-1 transcription factor complex
EF Wagner, et al.
Arthritis Res 2001, 3(Suppl A):L025 (26 January 2001)
[Full text] [PDF]
Meeting abstract
Anti-keratin antibodies in juvenile idiopathic arthritis
I Hromadnikova, P Vavrincova, K Stechova, D Hridelova, J Vavrinec
Arthritis Res 2001, 3(Suppl A):P001 (26 January 2001)
[Full text] [PDF]
| |
|  |
